195 related articles for article (PubMed ID: 30508568)
1. Exosomes and cells from lung cancer pleural exudates transform LTC4 to LTD4, promoting cell migration and survival via CysLT1.
Lukic A; Wahlund CJE; Gómez C; Brodin D; Samuelsson B; Wheelock CE; Gabrielsson S; Rådmark O
Cancer Lett; 2019 Mar; 444():1-8. PubMed ID: 30508568
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary epithelial cancer cells and their exosomes metabolize myeloid cell-derived leukotriene C4 to leukotriene D4.
Lukic A; Ji J; Idborg H; Samuelsson B; Palmberg L; Gabrielsson S; Rådmark O
J Lipid Res; 2016 Sep; 57(9):1659-69. PubMed ID: 27436590
[TBL] [Abstract][Full Text] [Related]
3. Leukotriene C4 induces bronchoconstriction and airway vascular hyperpermeability via the cysteinyl leukotriene receptor 2 in S-hexyl glutathione-treated guinea pigs.
Yonetomi Y; Sekioka T; Kadode M; Kitamine T; Kamiya A; Matsumura N; Fujita M; Kawabata K
Eur J Pharmacol; 2015 May; 754():98-104. PubMed ID: 25704617
[TBL] [Abstract][Full Text] [Related]
4. Characterization of cysteinyl leukotriene receptors on human saphenous veins: antagonist activity of montelukast and its metabolites.
Mechiche H; Candenas L; Pinto FM; Nazeyrollas P; Clément C; Devillier P
J Cardiovasc Pharmacol; 2004 Jan; 43(1):113-20. PubMed ID: 14668576
[TBL] [Abstract][Full Text] [Related]
5. Cysteinyl leukotriene receptors.
Evans JF
Prostaglandins Other Lipid Mediat; 2002 Aug; 68-69():587-97. PubMed ID: 12432945
[TBL] [Abstract][Full Text] [Related]
6. A new CysLT
Sekioka T; Kadode M; Osakada N; Fujita M; Matsumura N; Yamaura Y; Nakade S; Nabe T; Kawabata K
Prostaglandins Leukot Essent Fatty Acids; 2017 Apr; 119():18-24. PubMed ID: 28410666
[TBL] [Abstract][Full Text] [Related]
7. Cysteinyl leukotriene receptor (CysLT) antagonists decrease pentylenetetrazol-induced seizures and blood-brain barrier dysfunction.
Lenz QF; Arroyo DS; Temp FR; Poersch AB; Masson CJ; Jesse AC; Marafiga JR; Reschke CR; Iribarren P; Mello CF
Neuroscience; 2014 Sep; 277():859-71. PubMed ID: 25090924
[TBL] [Abstract][Full Text] [Related]
8. [Leukotriene D4 activates BV2 microglia in vitro].
Zhang Z; Luo J; Huang J; Liu Z; Fang S; Zhang WP; Wei E; Lu Y
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 May; 42(3):253-60. PubMed ID: 23801612
[TBL] [Abstract][Full Text] [Related]
9. Identification of cysteinyl-leukotriene-receptor 1 antagonists as ligands for the bile acid receptor GPBAR1.
Biagioli M; Carino A; Marchianò S; Roselli R; Di Giorgio C; Bordoni M; Fiorucci C; Sepe V; Conflitti P; Limongelli V; Distrutti E; Baldoni M; Zampella A; Fiorucci S
Biochem Pharmacol; 2020 Jul; 177():113987. PubMed ID: 32330496
[TBL] [Abstract][Full Text] [Related]
10. Inhaled montelukast inhibits cysteinyl-leukotriene-induced bronchoconstriction in ovalbumin-sensitized guinea-pigs: the potential as a new asthma medication.
Muraki M; Imbe S; Sato R; Ikeda Y; Yamagata S; Iwanaga T; Tohda Y
Int Immunopharmacol; 2009 Oct; 9(11):1337-41. PubMed ID: 19706339
[TBL] [Abstract][Full Text] [Related]
11. Effects of cysteinyl leukotrienes in small human bronchus and antagonist activity of montelukast and its metabolites.
Mechiche H; Naline E; Candenas L; Pinto FM; Birembault P; Advenier C; Devillier P
Clin Exp Allergy; 2003 Jul; 33(7):887-94. PubMed ID: 12859443
[TBL] [Abstract][Full Text] [Related]
12. Leukotriene C
Fujimori K; Uno S; Kuroda K; Matsumoto C; Maehara T
Biochim Biophys Acta Mol Cell Res; 2022 Mar; 1869(3):119203. PubMed ID: 34968576
[TBL] [Abstract][Full Text] [Related]
13. Leukotriene D
Al-Azzam N; Elsalem L
Life Sci; 2020 Nov; 260():118452. PubMed ID: 32956660
[TBL] [Abstract][Full Text] [Related]
14. Toll-like receptor agonists differentially regulate cysteinyl-leukotriene receptor 1 expression and function in human dendritic cells.
Thivierge M; Stankova J; Rola-Pleszczynski M
J Allergy Clin Immunol; 2006 May; 117(5):1155-62. PubMed ID: 16675346
[TBL] [Abstract][Full Text] [Related]
15. Involvement of cysteinyl leukotriene receptors in angiogenesis in rat thoracic aortic rings.
Xu L; Zhang L; Liu L; Fang S; Lu Y; Wei E; Zhang W
Pharmazie; 2010 Oct; 65(10):750-4. PubMed ID: 21105577
[TBL] [Abstract][Full Text] [Related]
16. Chemotaxis and transendothelial migration of CD34(+) hematopoietic progenitor cells induced by the inflammatory mediator leukotriene D4 are mediated by the 7-transmembrane receptor CysLT1.
Bautz F; Denzlinger C; Kanz L; Möhle R
Blood; 2001 Jun; 97(11):3433-40. PubMed ID: 11369634
[TBL] [Abstract][Full Text] [Related]
17. Neutralization of leukotriene C4 and D4 activity by monoclonal and single-chain antibodies.
Kawakami Y; Hirano S; Kinoshita M; Otsuki A; Suzuki-Yamamoto T; Suzuki M; Kimoto M; Sasabe S; Fukushima M; Kishimoto K; Izumi T; Oga T; Narumiya S; Sugahara M; Miyano M; Yamamoto S; Takahashi Y
Biochim Biophys Acta; 2014 Jun; 1840(6):1625-33. PubMed ID: 24361619
[TBL] [Abstract][Full Text] [Related]
18. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
Bäck M
Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
[TBL] [Abstract][Full Text] [Related]
19. The G protein-coupled receptor CysLT1 mediates chemokine-like effects and prolongs survival in chronic lymphocytic leukemia.
Drost AC; Seitz G; Boehmler A; Funk M; Norz KP; Zipfel A; Xue X; Kanz L; Möhle R
Leuk Lymphoma; 2012 Apr; 53(4):665-73. PubMed ID: 21936770
[TBL] [Abstract][Full Text] [Related]
20. Cysteinyl leukotrienes induce IL-4 release from cord blood-derived human eosinophils.
Bandeira-Melo C; Hall JC; Penrose JF; Weller PF
J Allergy Clin Immunol; 2002 Jun; 109(6):975-9. PubMed ID: 12063527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]